Does Pomegranate Juice Really Clean Arteries?

We review the scientific evidence on pomegranate juice, its bioactive components, and its actual impact on arterial plaque and cardiovascular health markers.

Pomegranate juice does not “clean” arteries in the way viral health claims suggest, but it is not pure hype either. A small but real body of research shows that drinking pomegranate juice can lower blood pressure, reduce markers of inflammation, and protect LDL cholesterol from the oxidative damage that contributes to plaque buildup. One frequently cited Israeli study even found that artery-wall thickness shrank in patients who drank pomegranate juice daily for a year. Yet when a much larger trial tried to replicate that result, the overall effect disappeared. The truth sits in a familiar place for nutrition science: genuinely interesting biology, some encouraging numbers, and not nearly enough evidence to call it a treatment for cardiovascular disease.

The Study That Launched a Thousand Headlines

Most of the “pomegranate juice unclogs arteries” narrative traces back to a single study published in 2004 by researcher Michael Aviram and colleagues. They gave a small group of patients with severe carotid artery narrowing about 50 milliliters of pomegranate juice daily and followed them for up to three years. In the patients who did not drink the juice, the thickness of their carotid artery walls increased by about 9 percent over one year. In the pomegranate group, that thickness dropped by up to 30 percent after a year. At the same time, LDL oxidation fell dramatically, systolic blood pressure dropped by roughly 12 percent, and antioxidant activity in the blood more than doubled.

Those numbers are striking, and they are frequently quoted without context. The study enrolled only 19 people, lacked blinding, and the participants already had significant artery disease. It was, in other words, a very small pilot with a very specific group of patients. That does not make it wrong, but it means the results should be treated as a hypothesis to test, not a conclusion to act on.

What Happened When a Bigger Trial Tried to Confirm It

In 2009, a randomized controlled trial enrolled 289 men and women at moderate risk for heart disease and had them drink 240 milliliters of pomegranate juice daily for up to 18 months. The researchers measured the same thing Aviram had measured: carotid artery wall thickness. The result was clear: no significant difference in the overall rate of artery-wall thickening between the pomegranate group and the control group.

There was one wrinkle. In exploratory analyses, people who started the trial with the worst lipid profiles and highest oxidative stress did show slower plaque progression in the pomegranate group. That is a suggestive finding, but exploratory subgroup analyses are hypothesis-generating, not proof. A separate trial in hemodialysis patients also found no effect of pomegranate extract on markers of cardiovascular disease risk, inflammation, or oxidative stress.

So the honest picture on artery thickness is this: one tiny study found a large benefit in patients with advanced disease, a much larger study found no general benefit but a possible signal in the highest-risk subgroup, and a third study found nothing. “Pomegranate juice cleans arteries” is a generous reading of that evidence.

Where the Evidence Is Actually Stronger

If artery-wall thickness is where the pomegranate story gets shaky, blood pressure is where it holds up better. A meta-analysis pooling data from eight randomized controlled trials found that pomegranate juice consumption lowered systolic blood pressure by about 5 mmHg and diastolic pressure by about 2 mmHg on average. The effect held regardless of whether people drank the juice for more or less than 12 weeks. Individual trials back this up. In people with hypertension, a single serving of pomegranate juice lowered systolic pressure by about 7 percent and diastolic by about 6 percent. In patients with type 2 diabetes, six weeks of daily juice also brought blood pressure down significantly compared to controls.

A 5 mmHg drop in systolic pressure is not dramatic when you read it on a page, but at a population level, sustained reductions that size are associated with meaningfully lower rates of stroke and heart attack. That said, pomegranate juice had no effect on arterial stiffness (measured by pulse wave velocity) in healthy young and middle-aged adults, suggesting the blood pressure benefit does not necessarily translate into structural changes in blood vessel walls.

Effects on Cholesterol and Blood Fats

A 2023 meta-analysis of multiple trials found that pomegranate consumption modestly lowered triglycerides (by roughly 13 mg/dL), lowered LDL cholesterol (by about 3 mg/dL), and raised HDL cholesterol (by about 2.5 mg/dL). Total cholesterol did not change significantly. These shifts are real but small compared to what statin drugs accomplish. An earlier trial in diabetic patients with high cholesterol found larger drops in total and LDL cholesterol with concentrated pomegranate juice, but that was a single small study in an already high-risk group.

What may matter more than the raw cholesterol numbers is what pomegranate does to LDL quality. In lab studies, pomegranate juice reduced macrophage uptake of oxidized LDL by about 40 percent and cut cholesterol production within macrophages by half. Oxidized LDL is the form of “bad cholesterol” that immune cells gobble up and pack into artery walls, so making LDL harder to oxidize and harder for immune cells to absorb could, in theory, slow plaque growth. A review article summarizing this research described pomegranate as “superior in comparison to other antioxidants” at protecting both LDL and HDL from oxidation. Whether that laboratory superiority translates into a clinical advantage over, say, eating more berries or vegetables is an open question.

What Pomegranate Does Inside Blood Vessels

The inner lining of blood vessels relies on nitric oxide to stay relaxed and flexible. When oxidized LDL accumulates, it suppresses the enzyme that produces nitric oxide, making arteries stiffer and more prone to damage. In human coronary endothelial cells, pomegranate juice reversed that suppression: cells treated with both oxidized LDL and pomegranate juice maintained their nitric oxide production much better than cells treated with oxidized LDL alone.

Interestingly, the mechanism seems to be protective rather than stimulatory. A separate study found that pomegranate juice did not boost the enzyme that makes nitric oxide or increase its production directly. Instead, it protected the nitric oxide that was already there from being destroyed by oxidative stress. In animal models, pomegranate juice also reduced the activity of stress-response genes in areas of arteries where turbulent blood flow makes plaque most likely to form, while increasing nitric oxide synthase expression in those vulnerable spots.

These are compelling lab and animal findings. They give a plausible mechanism for how pomegranate juice could help protect arteries. But a mechanism in a petri dish or a mouse is not the same as a proven benefit in a human body, and the jump from “protects nitric oxide in a cell culture” to “cleans your arteries” is enormous.

Inflammation and Blood Clotting

Chronic inflammation drives atherosclerosis at every stage, so anything that lowers systemic inflammation markers is at least theoretically cardioprotective. Two meta-analyses have found that pomegranate juice lowers C-reactive protein (CRP), a widely used marker of inflammation. One reported an average CRP drop of about 0.5 mg/L across pooled trials. Another found a larger reduction, though confidence intervals were wider. In a single trial of type 2 diabetic patients, 12 weeks of pomegranate juice cut CRP by about a third and the inflammatory marker interleukin-6 by about 30 percent.

Pomegranate polyphenols also appear to reduce platelet clumping. In lab experiments, both pomegranate juice and a polyphenol-rich pomegranate extract reduced platelet aggregation, calcium mobilization inside platelets, and production of thromboxane A2, a molecule that promotes clotting. The extract was active at concentrations achievable through normal dietary intake. Animal studies have confirmed these antiplatelet and anticoagulant effects, including prolonged bleeding time in rats treated with pomegranate extract. If you are on blood thinners, this is worth flagging with your doctor, since stacking antiplatelet effects could increase bleeding risk.

Why Your Gut Bacteria Change What You Get From the Juice

One reason pomegranate research produces inconsistent results across people may come down to gut microbiota. The key polyphenols in pomegranate, called ellagitannins, are barely absorbed on their own. Instead, gut bacteria break them down into smaller molecules called urolithins, which are absorbed much more readily. The catch is that not everyone’s gut bacteria perform this conversion the same way. People fall into distinct “metabotypes” based on which urolithins they produce and how efficiently they do it.

A study using a simulated gut model showed that two individuals with different metabotypes produced substantially different urolithin profiles from the same pomegranate polyphenols. Microbial composition, short-chain fatty acid production, and the metabolism of ellagitannins all varied between the two metabotypes and across different regions of the simulated large intestine. This means two people drinking the exact same glass of pomegranate juice might absorb very different amounts of its active metabolites. It could partly explain why some trials find robust effects while others find nothing.

Not All Pomegranate Juice Is Equal

If you walk through a grocery store, the pomegranate juice options range from fresh-pressed to heavily processed blends where pomegranate is the third or fourth ingredient. Processing matters. A study tracking how different manufacturing steps affect polyphenol content found that the highest levels of beneficial compounds came from juicing steamed whole fruits with minimal further processing. Peeling the fruit before juicing and pressing only the seed-containing arils produced the lowest polyphenol content. Steps like microfiltration and clarification further reduced polyphenol levels. Storage mattered too: keeping juice at room temperature or under light caused significant pigment degradation, while cold dark storage preserved most of the non-anthocyanin polyphenols and antioxidant capacity.

This creates a practical problem: the pomegranate juice used in clinical trials, often made in small batches under controlled conditions, may bear little resemblance to what you buy off a shelf. Many commercial products are blends, diluted with cheaper juices, or processed in ways that strip out the polyphenols researchers are studying. If you want to get as close as possible to what the studies used, look for 100 percent pomegranate juice (not from concentrate, ideally) stored in dark bottles, and keep it refrigerated.

Drug Interactions and Sugar Content

Pomegranate juice, like grapefruit juice, has been investigated for its potential to interfere with drug-metabolizing enzymes. A review of fruit-drug interactions flagged that fruits can inhibit several enzyme families involved in processing medications, including statins and blood pressure drugs, sometimes leading to elevated drug levels and toxicity. However, a specific study testing pomegranate juice alongside simvastatin (a common statin) found no clinically meaningful effect on how the drug was processed. So the risk with statins seems low, but the broader picture with other medications is less clear. If you take blood thinners, blood pressure medications, or diabetes drugs, it is worth mentioning pomegranate juice to your prescriber, especially given the antiplatelet and blood-pressure-lowering effects noted above.

Then there is the sugar. An eight-ounce glass of pomegranate juice contains roughly 30 to 35 grams of sugar. For someone with type 2 diabetes, that is a lot of sugar to drink in one sitting, even though one trial found that fresh pomegranate juice actually improved insulin sensitivity and lowered fasting blood sugar in diabetic patients over several hours. The net effect of fruit sugars plus polyphenols on blood sugar control is complicated, and daily juice consumption adds meaningful calories.

Pomegranate Seed Oil and Punicic Acid

Most of the research and public conversation focuses on juice, but pomegranate seeds contain an oil rich in punicic acid, a conjugated fatty acid related to alpha-linolenic acid (an omega-3). Punicic acid has shown antioxidant and anti-inflammatory effects in preclinical research, and it may help manage lipid profiles and metabolic markers associated with obesity and diabetes. Pomegranate seed oil is available as a supplement, though the clinical trial base for it is much thinner than for pomegranate juice. It does highlight that the cardiovascular-relevant compounds in pomegranate extend beyond polyphenols alone, and that eating the whole fruit, seeds included, gives you a broader range of bioactive compounds than juice does.

How Pomegranate Compares to Proven Treatments

Large clinical trials have consistently shown that statins reduce the risk of cardiovascular events and improve survival in patients with coronary artery disease. A review in the Journal of the American College of Cardiology noted that the clinical data for antioxidant supplementation, including various polyphenol-rich foods, has been inconsistent, in stark contrast to the reliable results seen with lipid-lowering statin therapy. That does not mean antioxidant-rich foods are useless, but it does mean no one should be skipping a prescribed medication in favor of pomegranate juice.

The antioxidant capacity of pomegranate juice has been reported to be several times higher than that of red wine or green tea. That is an interesting laboratory measurement, but antioxidant capacity in a test tube does not map neatly onto health outcomes in people. Many foods with high measured antioxidant levels have failed to produce benefits in clinical trials. The gap between “high antioxidant score” and “prevents heart disease” is one of the most persistent disappointments in nutrition research, and pomegranate is no exception to the general uncertainty.

If your diet already includes plenty of fruits, vegetables, nuts, and whole grains, adding pomegranate juice might offer a small incremental boost to a few cardiovascular markers. If you are drinking it instead of eating those foods, or instead of taking medications your doctor has recommended, you are making a bad trade. Pomegranate juice is a food with genuinely interesting biological activity and a suggestive but incomplete evidence base. It is not a treatment, and calling it an artery cleaner is a stretch the data does not support.